Peregrine Capital Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-342,795
Closed -$12.6M 287
2026
Q1
$12.6M Buy
342,795
+47,074
+16% +$1.86M 0.47% 44
2025
Q4
$13.5M Sell
295,721
-18,147
-6% -$808K 0.41% 48
2025
Q3
$13.3M Sell
313,868
-2,829
-0.9% -$107K 0.4% 50
2025
Q2
$9.85M Buy
316,697
+5,473
+2% +$148K 0.3% 87
2025
Q1
$7.65M Buy
+311,224
New +$8.64M 0.25% 108

Other funds holding AORT

Peregrine Capital Management's AORT Position: Q2 2026 in Review

Peregrine Capital Management sold out of Artivion (AORT) in Q2 2026, closing a stake of 342,795 shares — an estimated $12.6M sold.

Peregrine Capital Management first reported a position in AORT in Q1 2025 and held it in 5 quarters. The position peaked at $13.5M in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Peregrine Capital Management reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Peregrine Capital Management sold 342,795 Artivion shares in Q2 2026, an estimated $12.6M.
  • Peregrine Capital Management first reported a position in Artivion in Q1 2025 and held it in 5 quarters.
  • Peregrine Capital Management's Artivion position peaked at $13.5M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.